Salubris Biotherapeutics Revenue and Competitors

Location

#6380

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Salubris Biotherapeutics's estimated annual revenue is currently $3.1M per year.(i)
  • Salubris Biotherapeutics's estimated revenue per employee is $77,500

Employee Data

  • Salubris Biotherapeutics has 40 Employees.(i)
  • Salubris Biotherapeutics grew their employee count by 18% last year.

Salubris Biotherapeutics's People

NameTitleEmail/Phone
1
VP, Clinical DevelopmentReveal Email/Phone
2
VP Clinical DevelopmentReveal Email/Phone
3
DirectorReveal Email/Phone
4
Human Resources DirectorReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Associate DirectorReveal Email/Phone
7
Director, CMCReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Operations ManagerReveal Email/Phone
10
Senior Clinical Trial ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Salubris Biotherapeutics?

SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com). SalubrisBio is an innovation-focused biotech with pioneering research and development programs. Headquartered in Gaithersburg, Maryland, SalubrisBio represents and reflects Salubris Pharmaceuticals’ commitment to innovation and expansion into the global market. SalubrisBio focuses exclusively on the discovery and global development of novel, biologic therapeutics. Salubris Pharmaceuticals is a publicly-traded company [002294:CH], founded in 1998, which has grown to achieve sales of >$750M USD in 2016. Salubris Pharmaceuticals is a fully-integrated drug development company. Headquartered in Shenzhen, China, Salubris Pharmaceuticals has over 3,000 employees working across R&D, regulatory, marketing and sales. Its marketed products include small molecule drugs in the cardiovascular, anti-allergy and anti-infective therapeutic areas. GeneKey Biotech Ltd. Co. (www.genekeybio.com), based in Chengdu, China, is the China-based biologics subsidiary of Salubris Pharmaceuticals. GeneKey Biotech has a robust portfolio of biosimilar and novel large molecule therapeutics in development in China. SalubrisBio maintains close cross-functional collaborations with GeneKey Biotech, leveraging resources including the expertise of >150 research scientists and large-scale manufacturing of up to 2000L scale.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$3.1M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.2M40-5%N/A
#2
$3.3M408%N/A
#3
$10.8M418%N/A
#4
N/A420%N/A
#5
$11.1M420%N/A